Additionally, exosomal EGFR can activate the AKT and MAPK signaling pathway to human umbilical vein endothelial cells (HUVECs) by conveying cancer cell-derived EGFR signals, which is accomplished via the presentation of intact EGFR kinase activity and phosphatidylserine (PS) [57,59]. This evidence concerns the gene EGFR and cancer.